Abstract Body

Background

Durable, treatment-free control is a key goal of HIV cure research. While spontaneous controllers have been shown to exhibit functional HIV-specific CD8+ T cell responses to mutationally constrained (“networked”) epitopes, an even rarer group with no detectable provirus or proviruses confined to transcriptionally repressed genomic regions (e.g. ‘San Francisco patient’) demonstrates a depth of control that exceeds existing paradigms. The immune features underlying this exceptional cure-like phenotype beyond epitope targeting alone remain incompletely defined.

Methods

We characterized HIV-specific CD8+ T cells targeting networked epitopes in exceptional spontaneous controllers and individuals on antiretroviral therapy (ART) by single-cell RNA sequencing. Comparative profiling of HIV-specific and CMV-specific CD8+ T cells was performed in an independent controller cohort. HIV-specific CD8+ T cell transcriptomes were compared to CD8+ T cells across various stages of hepatitis B virus (HBV) infection, including functional cure. KIR expression was quantified by flow cytometry, and autologous HIV-infected CD4+ T cell elimination was assessed with or without KIR+ CD8+ T cell depletion.

Results

Within HIV-specific CD8+ T cells, we identified a KIR+ CD8+ T cell subset enriched in spontaneous controllers and prominent in the ‘San Francisco patient’. This subset exhibited a distinct innate, NK-like and cytotoxic transcriptional program. In an independent cohort of controllers, scRNA-seq revealed selective enrichment of this NK-like subset within HIV-specific, but not CMV-specific, CD8+ T cells. Transcriptional programs closely overlapped with CD8+ T cells from individuals with functional HBV cure, indicating convergence on a conserved program. Flow cytometry confirmed enrichment of KIR+ CD8+ T cells in controllers relative to ART-suppressed progressors. Functionally, depletion of NK-like CD8+ T cells impaired elimination of autologous HIV-infected CD4+ T cells despite preserved recognition by networked HIV-specific CD8+ T cells.

Conclusions

We identify an NK-like KIR+ CD8+ T cell subset that synergizes with networked HIV-specific CD8+ T cells to mediate exceptional cure-like HIV control. Convergence of this immune program with HBV functional cure supports a conserved mechanism of durable viral suppression. These findings establish NK-like KIR+ CD8+ T cells as a previously unrecognized target for next-generation immunotherapies aimed at achieving remission or cure of chronic viral infections.